Multifocal Lymphangioendotheliomatosis with Thrombocytopenia: Presentation of Two Cases Treated with Sirolimus
Pediatric Dermatology2016Vol. 33(4), pp. e235–9
Citations Over TimeTop 15% of 2016 papers
Agustina Lanöel, Natalia Torres, Aurora Feliú, María Josefina Sala, Mariana Álvarez, Andrea Bettina Cervini
Abstract
Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT) is a rare disease characterized by congenital and progressive vascular lesions of the skin and gastrointestinal tract that may be associated with thrombocytopenia and possibly life-threatening gastrointestinal bleeding. Reports published on the disease and treatment strategies are scarce. We present two cases of MLT treated with sirolimus.
Related Papers
- → Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review(2019)54 cited
- Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.(2000)
- Application of sirolimus in drug-eluting stent(2009)
- Pharmacokinetics of Sirolimus in Subjects Treated with Intravitreal Sirolimus in the SAVE-2 Study: Sirolimus As Therapeutic Approach to UVEitis – Protocol 2 with Two Doses of Intravitreal Sirolimus(2018)
- → EXCELLENT ELEMENTS OF PRESENTATION IN BUSINESS ARENA(2023)